Write in a clean editor, then format for JAMA Oncology in one click — DocuGuru applies the official Clinical & Medical Journals template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
JAMA Oncology is a peer-reviewed journal published by Clinical & Medical Journals, covering Lung Cancer Treatments and Mutations, Cancer Immunotherapy and Biomarkers, Economic and Financial Impacts of Cancer. Over its lifetime it has published 4,827 papers, which have received 265,273 citations.
| Publisher | Clinical & Medical Journals |
|---|---|
| Reference style | Numbered (Vancouver) Numbered — [1], [2] in the text 1. Smith A, Jones B, Lee C. A representative article title. JAMA Oncology. 2023;12(3):45–58.
Formats any DOI in JAMA Oncology style. No sign-up. |
| Publishes research in | Lung Cancer Treatments and Mutations Cancer Immunotherapy and Biomarkers Economic and Financial Impacts of Cancer Breast Cancer Treatment Studies Cancer Genomics and Diagnostics |
| ISSN | 2374-2437 |
| Citation impact (2-yr) | 7.34 |
| h-index | 245 |
| i10-index | 1,985 |
| Top institutions publishing here | Harvard University |
| Journal website | jamanetwork.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
IMPORTANCE: Cancer is the second leading cause of death worldwide. Current estimates on the burden of cancer are needed for cancer control planning. OBJECTIVE: To estimate mortality, incidence, years lived with disability (YLDs), years of life lost (YLLs), and disability-adjusted life-years (DALYs) for 32 cancers in 195 countries and territories from 1990 to 2015. EVIDENCE…
IMPORTANCE: The incidence and prevalence of neuroendocrine tumors (NETs) are thought to be rising, but updated epidemiologic data are lacking. OBJECTIVE: To explore the evolving epidemiology and investigate the effect of therapeutic advances on survival of patients with NETs. DESIGN, SETTING, AND PARTICIPANTS: A retrospective, population-based study using nationally representative data from the Surveillance, Epidemiology,…
IMPORTANCE: Cancer is among the leading causes of death worldwide. Current estimates of cancer burden in individual countries and regions are necessary to inform local cancer control strategies. OBJECTIVE: To estimate mortality, incidence, years lived with disability (YLDs), years of life lost (YLLs), and disability-adjusted life-years (DALYs) for 28 cancers in 188 countries by sex…
<h3>Importance</h3> Cancer and other noncommunicable diseases (NCDs) are now widely recognized as a threat to global development. The latest United Nations high-level meeting on NCDs reaffirmed this observation and also highlighted the slow progress in meeting the 2011 Political Declaration on the Prevention and Control of Noncommunicable Diseases and the third Sustainable Development Goal. Lack…
Importance: Immune checkpoint inhibitors (ICIs) are now a mainstay of cancer treatment. Although rare, fulminant and fatal toxic effects may complicate these otherwise transformative therapies; characterizing these events requires integration of global data. Objective: To determine the spectrum, timing, and clinical features of fatal ICI-associated toxic effects. Design, Setting, and Participants: We retrospectively queried a…
